CanCURE would like to express its commitment to the fight against the HIV pandemic on this World AIDS Day 2016. The Team's research program aimed at developing strategies towards an HIV Cure is part of Canada's contribution to the global AIDS response.
CanCURE members recently convened for their 3rd Annual Meeting last November 9, 10 and 11 at the Institut de recherches cliniques de Montréal (IRCM) / Montreal Clinical Research Institute. On this occasion, the Team's scientific investigators presented the progress of their research projects. Students, postdoctoral fellows and research associates showcased the results of their work during poster sessions and prizes of distinction were awarded to the best presenters. Members of CanCURE's Scientific Advisory Board attended the meeting to give their insight on the research program's orientations. Representatives of industrial partners, representatives of the CIHR HIV/AIDS Initiative and external collaborators took part in the meeting, as well as members of CanCURE's Community Advisory Board who learned about the scientific progress and provided the views of people living with HIV.
Awardees of the poster competition prizes, from left to right: Scott Sugden (Postdoctoral Fellow awardee), Éric A. Cohen (CanCURE Team Leader), Teslin Sandstrom (Ph.D. awardee), Marion Pardons (Ph.D. awardee)
Keynote speaker Dr. Michael M. Lederman, M.D. (Scott R. Inkley Professor of Medicine at Case Western Reserve University, Cleveland) presented his views on the obstacles blocking the pathway towards HIV remission in affected individuals and on the various promising therapeutic strategies which could lead to such an accomplishment.
The African and Caribbean Council on HIV/AIDS in Ontario (ACCHO) has collaborated with CanCURE to develop an HIV Cure fact sheet. It is designed to assist African, Caribbean and Black (ACB) communities, service providers who work with them and other stakeholders in demystifying HIV Cure and increasing knowledge and awareness of the complexities of the search for a Cure.
Close to 100 participants involved in CanCURE's research program gathered November 9, 10 and 11 at the IRCM for the consortium's 3rd Annual Meeting